SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-018044
Filing Date
2021-10-07
Accepted
2021-10-07 17:11:50
Documents
2
Period of Report
2021-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1752
2 POWER OF ATTORNEY alanashworthpoa.htm EX-24.1 7733
  Complete submission text file 0001567619-21-018044.txt   10885
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Ashworth Alan (Reporting) CIK: 0001886426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 211313060